Article thumbnail

High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity

By Renato Millioni, Serena Tolin, Lucia Puricelli, Stefano Sbrignadello, Gian Paolo Fadini, Paolo Tessari and Giorgio Arrigoni
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3087803
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A high confidence, manually validated human blood plasma protein reference set.
  2. (2005). A modified protein precipitation procedure for efficient removal of albumin from serum.
  3. (2010). A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/ MS.
  4. (2010). A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.
  5. (2005). Albumin depletion of human plasma also removes low abundance proteins including the cytokines.
  6. (2003). An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum.
  7. (2010). Bachi A
  8. (2010). Blood-related proteomics.
  9. (2005). Characterization of the human blood plasma proteome.
  10. (2010). Combinatorial peptide ligand library plasma treatment: Advantages for accessing lowabundance proteins.
  11. (2010). Comparison of protein enrichment strategies for proteome analysis of plasma.
  12. (2005). Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma.
  13. (2009). Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better?
  14. (2004). Determination of protein markers in human serum: Analysis of protein expression in toxic oil syndrome studies.
  15. (2005). Differences among techniques for high-abundant protein depletion.
  16. (2006). Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
  17. (2005). Effective removal of albumin from serum.
  18. (2008). Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
  19. (2008). Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
  20. (2005). Exploring the hidden human urinary proteome via ligand library beads.
  21. (2007). Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries.
  22. (2008). Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry.
  23. (2006). High dynamic range characterization of the trauma patient plasma proteome.
  24. (2010). High-abundance protein depletion: comparison of methods for human plasma biomarker discovery.
  25. (2005). High-sensitivity analysis of human plasma proteome by immobilized isoelectric focusing fractionation coupled to mass spectrometry identification.
  26. (2010). Highabundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids. Depletion vs Enrichment for Plasma Proteome
  27. (2007). Higher dimensional (HiD) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
  28. (2005). HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
  29. (2005). Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
  30. (1951). Protein measurement with the Folin phenol reagent.
  31. (2007). Proteomic analysis of human blood serum using peptide library beads.
  32. (2007). Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.
  33. (2004). Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins.
  34. (2008). Quantitative assessment of human serum high-abundance protein depletion.
  35. (2008). Rapid, simple and effective technical procedure for the regeneration of IgG and HSA affinity columns for proteomic analysis.
  36. (2006). Reducing protein concentration range of biological samples using solid-phase ligand libraries.
  37. (2003). Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion.
  38. (2008). Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?
  39. (2009). Study of the human plasma proteome of rheumatoid arthritis.
  40. (2008). The ProteoMiner in the proteomic arena: a nondepleting tool for discovering low-abundance species.
  41. (2007). The use of a quantitative cysteinyl-peptide enrichment technology for high-throughput quantitative proteomics.